Viking Global Opportunities Parent GP LLC sold $11.3M of Inhibrx Biosciences (INBX)

Executed Oct 7 2025, disclosed Oct 9 2025, 2 days later.

Value, as filed

$11.3M

350,000 sh across 3 lots

Executed

Oct 7 2025

the trade date, as filed

Disclosed

Oct 9 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

VL Viking Global Opportunities Parent GP LLC 10% owner profile →

Viking Global Opportunities Parent GP LLC (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in Inhibrx Biosciences, Inc. (INBX). The largest single filing was $11.3M of INBX (350,000 sh across 3 lots, as filed), executed Oct 7 2025.

The name

INBX Inhibrx Biosciences, Inc. INBX · Healthcare · 7 filings in 24 months ticker →

Healthcare · Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→